1. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities;H. EI-Gabalawy,2010
2. Ottawa. Tocilizumab (Actemra): Adult patients with moderately to severely active rheumatoid arthritis, Canadian agency for drugs and technologies in health. 2015.
3. IL-6 in inflammation, immunity, and disease;T. Tanaka,2014
4. Interleukin-1 in the pathogenesis and treatement of inflammatory diseases;C.A. Dinarello,2011